BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28412468)

  • 1. A computationally simple central monitoring procedure, effectively applied to empirical trial data with known fraud.
    van den Bor RM; Vaessen PWJ; Oosterman BJ; Zuithoff NPA; Grobbee DE; Roes KCB
    J Clin Epidemiol; 2017 Jul; 87():59-69. PubMed ID: 28412468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central statistical monitoring: detecting fraud in clinical trials.
    Pogue JM; Devereaux PJ; Thorlund K; Yusuf S
    Clin Trials; 2013 Apr; 10(2):225-35. PubMed ID: 23283577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for dealing with fraud in clinical trials.
    Herson J
    Int J Clin Oncol; 2016 Feb; 21(1):22-7. PubMed ID: 26194810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Appraisal of the Carlisle-Stouffer-Fisher Method for Assessing Study Data Integrity and Fraud.
    Mascha EJ; Vetter TR; Pittet JF
    Anesth Analg; 2017 Oct; 125(4):1381-1385. PubMed ID: 28786843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research misconduct and data fraud in clinical trials: prevalence and causal factors.
    George SL
    Int J Clin Oncol; 2016 Feb; 21(1):15-21. PubMed ID: 26289019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinician-trialist rounds: 19. Faux pas or fraud? Identifying centers that have fabricated their data in your multi-center trial.
    Pogue J; Sackett DL
    Clin Trials; 2014 Feb; 11(1):128-30. PubMed ID: 24096634
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials.
    Buyse M; George SL; Evans S; Geller NL; Ranstam J; Scherrer B; Lesaffre E; Murray G; Edler L; Hutton J; Colton T; Lachenbruch P; Verma BL
    Stat Med; 1999 Dec; 18(24):3435-51. PubMed ID: 10611617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring.
    Trotta L; Kabeya Y; Buyse M; Doffagne E; Venet D; Desmet L; Burzykowski T; Tsuburaya A; Yoshida K; Miyashita Y; Morita S; Sakamoto J; Praveen P; Oba K
    Clin Trials; 2019 Oct; 16(5):512-522. PubMed ID: 31331195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrity of scientific data: transparency of clinical trial data.
    Moore N; Juillet Y; Bertoye PH;
    Therapie; 2007; 62(3):203-9, 211-6. PubMed ID: 17803887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A statistical approach to central monitoring of data quality in clinical trials.
    Venet D; Doffagne E; Burzykowski T; Beckers F; Tellier Y; Genevois-Marlin E; Becker U; Bee V; Wilson V; Legrand C; Buyse M
    Clin Trials; 2012 Dec; 9(6):705-13. PubMed ID: 22684241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring.
    de Viron S; Trotta L; Schumacher H; Lomp HJ; Höppner S; Young S; Buyse M
    Ther Innov Regul Sci; 2022 Jan; 56(1):130-136. PubMed ID: 34590286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of methods for central statistical monitoring in clinical trials.
    Kirkwood AA; Cox T; Hackshaw A
    Clin Trials; 2013 Oct; 10(5):783-806. PubMed ID: 24130202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are these data real? Statistical methods for the detection of data fabrication in clinical trials.
    Al-Marzouki S; Evans S; Marshall T; Roberts I
    BMJ; 2005 Jul; 331(7511):267-70. PubMed ID: 16052019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of data audits in detecting scientific misconduct. Results of the FDA program.
    Shapiro MF; Charrow RP
    JAMA; 1989 May; 261(17):2505-11. PubMed ID: 2704109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific authorship. Part 1. A window into scientific fraud?
    Claxton LD
    Mutat Res; 2005 Jan; 589(1):17-30. PubMed ID: 15652224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retractions in the scientific literature: do authors deliberately commit research fraud?
    Steen RG
    J Med Ethics; 2011 Feb; 37(2):113-7. PubMed ID: 21081306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the potential cost effectiveness of scientific audits.
    Click JL
    Account Res; 1989 Sep; 1(1):77-83. PubMed ID: 26859058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting data fabrication in clinical trials from cluster analysis perspective.
    Wu X; Carlsson M
    Pharm Stat; 2011; 10(3):257-64. PubMed ID: 20936626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear mixed-effects models for central statistical monitoring of multicenter clinical trials.
    Desmet L; Venet D; Doffagne E; Timmermans C; Burzykowski T; Legrand C; Buyse M
    Stat Med; 2014 Dec; 33(30):5265-79. PubMed ID: 25213096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.